[PDF][PDF] COVID-19-neutralizing antibodies predict disease severity and survival
…, MR Murali, G Alter, RC Charles, A Dighe, JA Branda… - Cell, 2021 - cell.com
Coronavirus disease 2019 (COVID-19) exhibits variable symptom severity ranging from
asymptomatic to life-threatening, yet the relationship between severity and the humoral immune …
asymptomatic to life-threatening, yet the relationship between severity and the humoral immune …
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
…, BM Hauser, TM Caradonna, JA Branda… - Science …, 2020 - science.org
We measured plasma and/or serum antibody responses to the receptor-binding domain (RBD)
of the spike (S) protein of SARS-CoV-2 in 343 North American patients infected with …
of the spike (S) protein of SARS-CoV-2 in 343 North American patients infected with …
[HTML][HTML] Lyme borreliosis
…, F Strle, GP Wormser, LT Hu, JA Branda… - Nature reviews Disease …, 2016 - nature.com
Lyme borreliosis is a tick-borne disease that predominantly occurs in temperate regions of
the northern hemisphere and is primarily caused by the bacterium Borrelia burgdorferi in …
the northern hemisphere and is primarily caused by the bacterium Borrelia burgdorferi in …
Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology …
…, KK Belani, WR Bowie, JA Branda… - Clinical Infectious …, 2021 - academic.oup.com
This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment
of Lyme disease was developed by a multidisciplinary panel representing the Infectious …
of Lyme disease was developed by a multidisciplinary panel representing the Infectious …
[HTML][HTML] Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants
…, BL MacInnis, JE Lemieux, E Rosenberg, JA Branda… - Nature Medicine, 2022 - nature.com
The coronavirus disease 2019 (COVID-19) pandemic has demonstrated a clear need for
high-throughput, multiplexed and sensitive assays for detecting severe acute respiratory …
high-throughput, multiplexed and sensitive assays for detecting severe acute respiratory …
Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events
…, F Cerrato, M Farhat, D Slater, JB Harris, JA Branda… - Science, 2021 - science.org
INTRODUCTION We used genomic epidemiology to investigate the introduction and spread
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the Boston area …
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the Boston area …
[HTML][HTML] Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital
The diagnosis of COVID‐19 requires integration of clinical and laboratory data. Severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) diagnostic assays play a central role in …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) diagnostic assays play a central role in …
Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide …
JA Branda, K Linskey, YA Kim… - Clinical infectious …, 2011 - academic.oup.com
Background. Lyme disease (LD) antibody testing currently involves a 2-tiered algorithm with
a whole-cell sonicate (WCS) enzyme immunoassay (EIA), followed by IgM/IgG Western …
a whole-cell sonicate (WCS) enzyme immunoassay (EIA), followed by IgM/IgG Western …
Clinical practice guidelines by the Infectious Diseases Society of America (IDSA): 2020 guideline on diagnosis and management of babesiosis
…, PG Auwaerter, RR Bannuru, JA Branda… - Clinical Infectious …, 2021 - academic.oup.com
The purpose of this guideline is to provide evidence-based guidance for the most effective
strategies for the diagnosis and management of babesiosis. The diagnosis and treatment of co…
strategies for the diagnosis and management of babesiosis. The diagnosis and treatment of co…
Multicenter evaluation of the Vitek MS matrix-assisted laser desorption ionization–time of flight mass spectrometry system for identification of Gram-positive aerobic …
…, LF Westblade, MJ Ferraro, JA Branda - Journal of clinical …, 2013 - Am Soc Microbiol
Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF) is
gaining momentum as a tool for bacterial identification in the clinical microbiology laboratory. …
gaining momentum as a tool for bacterial identification in the clinical microbiology laboratory. …